BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 16339911)

  • 1. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
    Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
    J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines.
    Culley FJ; Fadlon EJ; Kirchem A; Williams TJ; Jose PJ; Pease JE
    Eur J Immunol; 2003 May; 33(5):1302-10. PubMed ID: 12731055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031.
    Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1217-23. PubMed ID: 16343433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G; Duchesnes CE; Williams TJ; Pease JE
    Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
    Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
    Eur J Pharmacol; 2007 Jun; 563(1-3):224-32. PubMed ID: 17336292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
    Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
    J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells.
    Tiffany HL; Alkhatib G; Combadiere C; Berger EA; Murphy PM
    J Immunol; 1998 Feb; 160(3):1385-92. PubMed ID: 9570558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
    Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
    Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.
    Sabroe I; Jorritsma A; Stubbs VE; Xanthou G; Jopling LA; Ponath PD; Williams TJ; Murphy PM; Pease JE
    Eur J Immunol; 2005 Apr; 35(4):1301-10. PubMed ID: 15739168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines induce eosinophil degranulation through CCR-3.
    Fujisawa T; Kato Y; Nagase H; Atsuta J; Terada A; Iguchi K; Kamiya H; Morita Y; Kitaura M; Kawasaki H; Yoshie O; Hirai K
    J Allergy Clin Immunol; 2000 Sep; 106(3):507-13. PubMed ID: 10984371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CC-chemokine receptor 3: a possible target in treatment of allergy-related corneal ulcer.
    Fukagawa K; Okada N; Fujishima H; Nakajima T; Tsubota K; Takano Y; Kawasaki H; Saito H; Hirai K
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):58-62. PubMed ID: 11773013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
    Duchesnes CE; Murphy PM; Williams TJ; Pease JE
    Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
    Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
    J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
    Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
    Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
    J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
    Parody TR; Stone MJ
    Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
    White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
    J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.